Week In Review: New York and Missouri’s Contrasting Cannabis Market Progress in 2023; Clearmind Medicine Inc. Announces Reverse Share Split to Comply with Nasdaq; Cybin Inc. Secures $30 Million in Funding to Advance Psychedelic Treatment Research
LOS ANGELES–Welcome to the far too-exciting world of cannabis and ...



























